Research demonstrates enhanced drug delivery with pH-responsive lipid nanoparticles, suggesting novel design strategies for endosomal escape.
While lipid nanoparticles (LNPs) are potent drug delivery vectors, endosomal escape remains a significant roadblock to efficient delivery. LNPs featuring inverse hexagonal or inverse cubic structures or pH-sensitive lipids have shown enhanced delivery over classic liposomal carriers. In hopes of leveraging both the structural and pH-sensitive handles, we have synthesized an ionizable glycerol monooleate (iGMO), which displays pH-sensitive transitions encompassing inverse cubic and hexagonal crystal structures. Here, we explore pH-dependent transitions in iGMO and compare this with behavior of iGMO-based LNPs through SAXS, Cryo-EM, and in vitro assays to measure fusogenicity with model early endosome membranes. Further, we characterize endosomal trafficking pathways of iGMO-based LNPs through immunofluorescence microscopy in contrast to previously reported cuboplexes, lipoplexes, and ionizable lipid LNPs.
No takes yet. Share an insight, caveat, or question.
Baliga et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: